The results showed the protein levels of EGFR and AKT were decreased in the tumor homogenates in both curcumin alone and curcumin combined with gefitinib groups, whereas, the c-MET, cyclin D1, and PCNA were also down-regulated simultaneously (Figure 5A). The gene discussed is MET; the disease is neoplasm.